Geron | GERN - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Amgen USD 9.13B 316M 2025-12
Bio Techne USD 172.88M 27.92M 2025-12
Cassava Sciences USD 106.08M 6.3M 2025-09
Cytokinetics USD 122.52M 102.95M 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Exelixis USD 482.49M 106.19M 2025-12
Genmab DKK 1.72B 46M 2025-12
Geron USD 79.44M 553K 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
Incyte USD 3.58B 650.78M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Novavax USD 240.63M 27.39M 2025-12